Chronic hepatitis B: Is it time for expanded antiviral treatment?

doi:10.5501/wjv.v14.i3.103347

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

(39)

(0)

(19)

(1379)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Virol. Sep 25, 2025; 14(3): 103347
Published online Sep 25, 2025. doi: 10.5501/wjv.v14.i3.103347

Table 4 Management of phase 3 of chronic hepatitis B virus infection

	APASL[11]	EASL[10]	AASLD[8,9]	INASL[12]	KASL[13]
Biopsy and treatment	Biopsy if ALT 1-2 × ULN or significant fibrosis on non-invasive assessment. Treat if > A2 or ≥ F2	Patients with HBeAg (-) disease and family history of HCC or cirrhosis, and extra-hepatic manifestations may be treated	Monitor	Monitor	Monitor

APASL: Asian Pacific Association for the Study of the Liver; EASL: European Association for the Study of the Liver; AASLD: American Association for the Study of Liver Diseases; INASL: Indian National Association for Study of the Liver; KASL: Korean Association for the Study of the Liver; ULN: Upper limit of normal; ALT: Alanine aminotransferase; HCC: Hepatocellular cancer.

Full Size Table

Citation: Manrai M, Jha AA, Pachisia AV, Dawra S. Chronic hepatitis B: Is it time for expanded antiviral treatment? World J Virol 2025; 14(3): 103347
URL: https://www.wjgnet.com/2220-3249/full/v14/i3/103347.htm
DOI: https://dx.doi.org/10.5501/wjv.v14.i3.103347

Manrai M, Jha AA, Pachisia AV, Dawra S. Chronic hepatitis B: Is it time for expanded antiviral treatment? World J Virol 2025; 14(3): 103347 [PMID: 41025085 DOI: 10.5501/wjv.v14.i3.103347]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.